Cervical low risk human papillomavirus (HPV) DNA test positive
ICD-10 R87.820 is a billable code used to indicate a diagnosis of cervical low risk human papillomavirus (hpv) dna test positive.
The ICD-10 code R87.820 is used to indicate a positive result for a cervical low-risk human papillomavirus (HPV) DNA test. Low-risk HPV types, such as HPV 6 and 11, are primarily associated with benign lesions, including genital warts and low-grade squamous intraepithelial lesions (LSIL). A positive test result indicates the presence of these low-risk HPV types in cervical cells, which may not necessarily lead to cervical cancer but can indicate the need for further monitoring and management. It is essential to differentiate between low-risk and high-risk HPV types, as the latter are associated with a higher risk of cervical cancer. The clinical context for this code often involves routine cervical cancer screening, where HPV testing is performed alongside Pap smears to assess the risk of cervical dysplasia. Proper documentation of the test results, patient history, and any follow-up actions taken is crucial for accurate coding and reimbursement.
Documentation should include the reason for the HPV test, results, and any follow-up plans.
Routine screening for cervical cancer in women aged 21 and older.
Consideration of patient's sexual history and HPV vaccination status is important.
Acute care documentation should include the patient's presenting symptoms and rationale for HPV testing.
Patients presenting with abnormal vaginal bleeding or discharge.
Emergency settings may require expedited documentation and follow-up plans.
Used when a patient undergoes HPV testing as part of cervical cancer screening.
Documentation of the test order, results, and any follow-up recommendations.
In gynecology, ensure that the test is linked to the appropriate diagnosis.
A positive low-risk HPV test indicates the presence of low-risk HPV types, which are generally associated with benign conditions like genital warts and low-grade cervical lesions. It does not indicate a high risk for cervical cancer, but monitoring and follow-up are recommended.
